We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Split-Night Sleep Apnea Diagnosis

By HospiMedica staff writers
Posted on 16 Mar 2006
Sleep apnea studies usually take place over two different nights, but now many sleep centers are doing split-night sleep studies in an effort to save time and money. More...
During the first part of the night, sleep specialists diagnose obstructive sleep apnea, and during the second half, they determine the appropriate level of positive airway pressure.

In traditional treatments, during the first night doctors perform a polysomnography (PSG), a diagnostic study that measures the apnea-hypopnea index (AHI). They may also perform a PSG if the patient has a respiratory disturbance index (RDI) of at least 20 events per hour, regardless of symptoms, or an AHI/RDI of 10 events per hour associated with excessive daytime somnolence. Once obstructive sleep apnea (OSA) has been confirmed, the patient returns for a second night, during which the doctor performs therapeutic PSG titration with either continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BiPAP) to levels that eliminate or significantly reduce the number of respiratory abnormalities.

Now, according to Dr. Stephen Baez, a medical specialist at AllMed HealthCare (Portland, OR, USA), split-night studies are gaining in popularity. For a split-night study to work, the patient must fall asleep promptly and demonstrate an elevated RDI of at least 40 events early in the evening. Only 25-30% of patients meet these guidelines. When they are met, the patient is awakened and fitted with a CPAP mask, which is adjusted to eliminate the respiratory events. If the patient fails to meet the split-night sleep study guidelines, the doctor follows traditional procedures for a two-night sleep study. Split-night studies are now incorporated into the guidelines for the treatment of OSA published by the American College of Chest Physicians (ACCP).

AllMed HealthCare is an independent review organization serving insurance payers, providers, third-party administrators, and claims managers.



Related Links:
AllMed

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.